You are here:

tapentadol film-coated tablets (Palexia)


In the absence of a submission from the holder of the marketing authorisation:
tapentadol film-coated tablets (Palexia®) is not recommended for use within NHS Scotland.
Indication under review: relief of moderate to severe acute pain in adults, which can be adequately managed only with opioid analgesics.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: tapentadol film-coated tablets (Palexia)
SMC Drug ID: 773/12
Manufacturer: GrĂ¼nenthal Ltd
Indication: Moderate to severe acute pain in adults
BNF Category:
Sub Category: 4.7 Analgesics
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 13 February 2012